MAPK/ERK


The mitogen-activated protein kinase (MAPK) is a highly conserved family of serine/threonine kinases that mediate a board range of cellular processes, including proliferation, differentiation, motility, migration, stress response, apoptosis and survival. The activation of MAPK involves signaling pathways consisting of MAPK kinase (i.e. MAPKKK or MEKK) that activates MAPK/ERK (i.e. MAPKK or MEK). A variety of extracellular signals such as mitogens, cytokines, growth factors, and environmental stressors stimulate a phosphorylation-dependent increase in the activity of MAPK.
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
C9127 TRi-1Summary: A selective irreversible TXNRD1 inhibitor for redox biology research. -
C9129 ASTX029Summary: A selective dual ERK1/2 inhibitor, small-molecule kinase tool compound, for research use only. -
BA5294A LY2510924 acetateSummary: An effective and selective CXCR4 antagonist -
C6299 AmantadineSummary: An antiviral and central dopaminergic modulator -
BA8332A UK122 HClSummary: UK122 is a potent and highly selective and cell-permeable uPA (Urokinase-type plasminogen activator) inhibitor -
BA8332B UK122 TFASummary: UK122 is a potent and highly selective and cell-permeable uPA (Urokinase-type plasminogen activator) inhibitor

